Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19030900rdf:typepubmed:Citationlld:pubmed
pubmed-article:19030900lifeskim:mentionsumls-concept:C0039552lld:lifeskim
pubmed-article:19030900lifeskim:mentionsumls-concept:C1516213lld:lifeskim
pubmed-article:19030900lifeskim:mentionsumls-concept:C0240320lld:lifeskim
pubmed-article:19030900pubmed:issue6lld:pubmed
pubmed-article:19030900pubmed:dateCreated2009-5-6lld:pubmed
pubmed-article:19030900pubmed:abstractTextCancer patients usually take many medications. The proportion of patients with advanced cancer who are taking futile drugs is unknown.lld:pubmed
pubmed-article:19030900pubmed:languageenglld:pubmed
pubmed-article:19030900pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19030900pubmed:citationSubsetIMlld:pubmed
pubmed-article:19030900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19030900pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19030900pubmed:statusMEDLINElld:pubmed
pubmed-article:19030900pubmed:monthJunlld:pubmed
pubmed-article:19030900pubmed:issn1433-7339lld:pubmed
pubmed-article:19030900pubmed:authorpubmed-author:KrzyzanowskaM...lld:pubmed
pubmed-article:19030900pubmed:authorpubmed-author:ZimmermannCam...lld:pubmed
pubmed-article:19030900pubmed:authorpubmed-author:RiechelmannRa...lld:pubmed
pubmed-article:19030900pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19030900pubmed:volume17lld:pubmed
pubmed-article:19030900pubmed:ownerNLMlld:pubmed
pubmed-article:19030900pubmed:authorsCompleteYlld:pubmed
pubmed-article:19030900pubmed:pagination745-8lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:meshHeadingpubmed-meshheading:19030900...lld:pubmed
pubmed-article:19030900pubmed:year2009lld:pubmed
pubmed-article:19030900pubmed:articleTitleFutile medication use in terminally ill cancer patients.lld:pubmed
pubmed-article:19030900pubmed:affiliationDepartment of Internal Medicine, Federal University of Sao Paulo, R: Luisiania 255, Apt 11, São Paulo, SP 04560-020, Brazil. rachelri@terra.com.brlld:pubmed
pubmed-article:19030900pubmed:publicationTypeJournal Articlelld:pubmed